Show simple item record

dc.contributor.authorWoll, P
dc.contributor.authorReichardt, P
dc.contributor.authorLe Cesne, A
dc.contributor.authorBonvalot, S
dc.contributor.authorAzzarelli, A
dc.contributor.authorHoekstra, H
dc.contributor.authorLeahy, Michael G
dc.contributor.authorVan Coevorden, F
dc.contributor.authorVerweij, J
dc.contributor.authorHogendoorn, P
dc.contributor.authorOuali, M
dc.contributor.authorMarreaud, S
dc.contributor.authorBramwell, Vivien H C
dc.contributor.authorHohenberger, P
dc.date.accessioned2012-12-28T15:51:22Z
dc.date.available2012-12-28T15:51:22Z
dc.date.issued2012-10
dc.identifier.citationAdjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. 2012, 13 (10):1045-54 Lancet Oncolen_GB
dc.identifier.issn1474-5488
dc.identifier.pmid22954508
dc.identifier.doi10.1016/S1470-2045(12)70346-7
dc.identifier.urihttp://hdl.handle.net/10541/263678
dc.description.abstractThe effect of adjuvant chemotherapy on survival for resected soft-tissue sarcoma remains unknown. We investigated the effect of intensive adjuvant chemotherapy on survival in patients after resection of high-risk soft-tissue sarcomas.
dc.language.isoenen
dc.rightsArchived with thanks to The lancet oncologyen_GB
dc.subject.meshAdolescent
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols
dc.subject.meshChemotherapy, Adjuvant
dc.subject.meshDoxorubicin
dc.subject.meshFemale
dc.subject.meshGranulocyte Colony-Stimulating Factor
dc.subject.meshHumans
dc.subject.meshIfosfamide
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshRecombinant Proteins
dc.subject.meshSarcoma
dc.titleAdjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.en
dc.typeArticleen
dc.contributor.departmentUniversity of Sheffield, Sheffield, UK.en_GB
dc.identifier.journalThe Lancet Oncologyen_GB
html.description.abstractThe effect of adjuvant chemotherapy on survival for resected soft-tissue sarcoma remains unknown. We investigated the effect of intensive adjuvant chemotherapy on survival in patients after resection of high-risk soft-tissue sarcomas.


Files in this item

This item appears in the following Collection(s)

Show simple item record